Inmolecule Nanotech (XPAR:MLINA) Stock Based Compensation: €0.00 Mil (TTM As of Dec. 2024)


XPAR:MLINA Inmolecule Nanotech SA XPAR:MLINA
6 GF Score
Price €4.08
! 2 Warning Signs
View Full Analysis

What is Inmolecule Nanotech Stock Based Compensation?

Inmolecule Nanotech XPAR:MLINA 6 Stock Based Compensation is €0.00 Mil as of Dec. 2024. GuruFocus rates XPAR:MLINA with a GF Score™ of 6/100. The stock has 2 warning signs investors should review.

Inmolecule Nanotech's Stock Based Compensation for the six months ended in Dec. 2024 was €0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

Inmolecule Nanotech Stock Based Compensation Related Terms

Inmolecule Nanotech Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Inmolecule Nanotech's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inmolecule Nanotech Stock Based Compensation Chart

Inmolecule Nanotech Annual Data
Trend Dec23 Dec24
Stock Based Compensation
0.00 0.00

Inmolecule Nanotech Semi-Annual Data
Dec23 Dec24
Stock Based Compensation 0.00 0.00
XPAR:MLINA
6GF Score
Inmolecule Nanotech SA XPAR:MLINA
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inmolecule Nanotech Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

What does a Stock Based Compensation of €0.00 Mil mean?
Inmolecule Nanotech (XPAR:MLINA) has a Stock Based Compensation of €0.00 Mil as of Dec. 2024. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Inmolecule Nanotech and its competitors.
Is Inmolecule Nanotech's Stock Based Compensation too high?
Inmolecule Nanotech's current Stock Based Compensation is €0.00 Mil. Overall, Inmolecule Nanotech has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Inmolecule Nanotech's Stock Based Compensation compare to VRTX and REGN?
Inmolecule Nanotech's Stock Based Compensation of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Biotechnology company?
A good Stock Based Compensation depends on the Biotechnology industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Inmolecule Nanotech and its competitors. Inmolecule Nanotech's current Stock Based Compensation is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inmolecule Nanotech stock overvalued right now?
Inmolecule Nanotech (XPAR:MLINA) has a current Stock Based Compensation of €0.00 Mil. The current Stock Based Compensation is €0.00 Mil. Inmolecule Nanotech's overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Inmolecule Nanotech (XPAR:MLINA), the current Stock Based Compensation is €0.00 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Inmolecule Nanotech Business Description

Address Paseo de la Castellana 91, 4th Floor, Madrid, ESP, 28046
Inmolecule Nanotech SA is a research and development company. The company provides health care, home care and personal care products.
6GF Score

Get the complete analysis for XPAR:MLINA

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.08
Price